
USFDA APPLICATION NUMBER - 204325 / DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - EQ 1.25MG BASE/ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| AMPHETAMINE(UNII: CK833KGX7E) (AMPHETAMINE - UNII:CK833KGX7E) | AMPHETAMINE | 1.25mg in 1 |
Inactive Ingredients
| Ingredient Name | Neos Therapeutics Brands, LLC | Prasco Laboratories |
|---|---|---|
| Citric Acid Monohydrate(2968PHW8QP) | ||
| Corn Oil(8470G57WFM) | ||
| METHACRYLIC ACID(1CS02G8656) | ||
| METHYLPARABEN(A2I8C7HI9T) | ||
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | ||
| PROPYLENE GLYCOL(6DC9Q167V3) | ||
| PROPYLPARABEN(Z8IX2SC1OH) | ||
| SODIUM POLYSTYRENE SULFONATE(1699G8679Z) | ||
| SORBITOL(506T60A25R) | ||
| Sucralose(96K6UQ3ZD4) | ||
| Triethyl Citrate(8Z96QXD6UM) | ||
| Water(059QF0KO0R) | ||
| Xanthan Gum(TTV12P4NEE) |